A man with Parkinson’s disease surprised his kids with dance moves after he regained movement thanks to a deep brain ...

Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's ...

Both Rising-Star Researchers and Senior Clinicians, and Advocates from around the World Present New Study Findings in ...

Catriona Kinnevey first started experiencing strange symptoms that she couldn't explain in her early 30s, but she never ...

Researchers identify GPNMB as a driver of Parkinson’s disease spread and demonstrate that monoclonal antibodies can block its activity to slow neurodegeneration.

Phase 3 ARISE trial of solengepras, a potential first-in-class non-dopaminergic therapy, is fully enrolled and topline data ...

Researchers have identified two proteins on the surface of neurons that may help drive the spread of Parkinson’s disease in ...

A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...

Is a Florida citrus "herbicide of choice" behind a cluster of Parkinson's disease among growers and researchers?

Clinical Expertise Backed by Real-World Experience ...

The approval of Sumitomo Pharma's Amchepry makes it the world's first commercialized medical product derived from iPS cells.